Media coverage
97
Media coverage
Title Epicentrx To Present Positive Phase 2A Clinical Data With Its Adapt-001 TGF-Β Trap Program In Checkpoint Inhibitor Resistant Patients At The 2024 AACR Meeting Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 2/04/24 Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet PR Newswire Country/Territory United States Date 2/04/24 URL https://www.prnewswire.com/news-releases/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf--trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting-302105991.html Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Street Insider Country/Territory United States Date 2/04/24 URL https://www.streetinsider.com/PRNewswire/EpicentRx+to+Present+Positive+Phase+2a+Clinical+Data+with+its+AdAPT-001+TGF-%CE%B2+Trap+Program+in+Checkpoint+Inhibitor+Resistant+Patients+at+the+2024+AACR+Meeting/23013927.html Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-? Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet InvestorsObserver Country/Territory United States Date 2/04/24 URL https://www.investorsobserver.com/news/qm-pr/7308554199913162 Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Finanzen.net Country/Territory Germany Date 2/04/24 URL https://www.finanzen.net/nachricht/aktien/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%CE%B2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting-13388507 Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet ProfitQuotes.com Country/Territory United States Date 2/04/24 URL www.profitquotes.com/cgi/?a=news&ticker=a&w=&story=202404202404021110PR_NEWS_USPR_____NY77717 Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor.. Media name/outlet ADVFN UK Country/Territory United Kingdom Date 2/04/24 URL https://uk.advfn.com/stock-market/share-news/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Da/93591801 Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet ADVFN US Country/Territory United States Date 2/04/24 URL https://www.advfn.com/stock-market/stock-news/93591801/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-tr Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KLFY Country/Territory United States Date 2/04/24 URL https://www.klfy.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WHNT-TV Country/Territory United States Date 2/04/24 URL https://whnt.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet MyStateLine.com Country/Territory United States Date 2/04/24 URL https://www.mystateline.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WYTV News Country/Territory United States Date 2/04/24 URL https://www.wytv.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KRON4 Country/Territory United States Date 2/04/24 URL https://www.kron4.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KTSM.com Country/Territory United States Date 2/04/24 URL https://www.ktsm.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WBOY Country/Territory United States Date 2/04/24 URL https://www.wboy.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet CNYHomepage.com Country/Territory United States Date 2/04/24 URL https://www.cnyhomepage.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WJBF-TV Country/Territory Georgia Date 2/04/24 URL https://www.wjbf.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet FOX8 WGHP Country/Territory United States Date 2/04/24 URL https://myfox8.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Texomashomepage.com Country/Territory United States Date 2/04/24 URL https://www.texomashomepage.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KELOLAND TV Country/Territory United States Date 2/04/24 URL https://www.keloland.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KSNT TV Country/Territory United States Date 2/04/24 URL https://www.ksnt.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WOWK Country/Territory United States Date 2/04/24 URL https://www.wowktv.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet MyHighPlains.com Country/Territory United States Date 2/04/24 URL https://www.myhighplains.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Kark.com Country/Territory United States Date 2/04/24 URL https://www.kark.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet My Champlain Valley Country/Territory United States Date 2/04/24 URL https://www.mychamplainvalley.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WSAV Country/Territory Georgia Date 2/04/24 URL https://www.wsav.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KGET Country/Territory United States Date 2/04/24 URL https://www.kget.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WNTZ Country/Territory United States Date 2/04/24 URL https://www.cenlanow.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WIProud.com Country/Territory United States Date 2/04/24 URL https://www.wiproud.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WYOU Country/Territory United States Date 2/04/24 URL https://www.pahomepage.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WSPA.com Country/Territory United States Date 2/04/24 URL https://www.wspa.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WBTW News13 Country/Territory United States Date 2/04/24 URL https://www.wbtw.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Wavy Country/Territory United States Date 2/04/24 URL https://www.wavy.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WDTN Country/Territory United States Date 2/04/24 URL https://www.wdtn.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KODE TV Country/Territory United States Date 2/04/24 URL https://www.fourstateshomepage.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WesternSlopeNow.com Country/Territory United States Date 2/04/24 URL https://www.westernslopenow.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet INFORMNNY.com Country/Territory United States Date 2/04/24 URL https://www.informnny.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WRIC TV Country/Territory United States Date 2/04/24 URL https://www.wric.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KXNet.com Country/Territory United States Date 2/04/24 URL https://www.kxnet.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Big Country Country/Territory United States Date 2/04/24 URL https://www.bigcountryhomepage.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet ABC 27 Country/Territory United States Date 2/04/24 URL https://www.abc27.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Binghamton Homepage Country/Territory United States Date 2/04/24 URL https://www.binghamtonhomepage.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Myarklamiss.com Country/Territory United States Date 2/04/24 URL https://www.myarklamiss.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet CW33 NewsFix Country/Territory United States Date 2/04/24 URL https://cw33.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WFXRTV.com Country/Territory United States Date 2/04/24 URL https://www.wfxrtv.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet LocalSRY.com Country/Territory United States Date 2/04/24 URL https://www.localsyr.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KXAN Country/Territory United States Date 2/04/24 URL https://www.kxan.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WJTV.com Country/Territory United States Date 2/04/24 URL https://www.wjtv.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Fox8 Country/Territory United States Date 2/04/24 URL https://fox8.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WIAT TV Country/Territory United States Date 2/04/24 URL https://www.cbs42.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet FOX 31 News KDVR Country/Territory United States Date 2/04/24 URL https://kdvr.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WKRG Country/Territory United States Date 2/04/24 URL https://www.wkrg.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KNWA Country/Territory United States Date 2/04/24 URL https://www.nwahomepage.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet CW39 NewsFix Country/Territory United States Date 2/04/24 URL https://cw39.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WeAreGreenBay.com Country/Territory United States Date 2/04/24 URL https://www.wearegreenbay.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KSN Country/Territory United States Date 2/04/24 URL https://www.ksn.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KRQE Country/Territory United States Date 2/04/24 URL https://www.krqe.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet CBS4Indy Country/Territory United States Date 2/04/24 URL https://cbs4indy.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Siouxland Matters Country/Territory United States Date 2/04/24 URL https://www.siouxlandproud.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WCIA.com Country/Territory United States Date 2/04/24 URL https://www.wcia.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WLNS Country/Territory United States Date 2/04/24 URL https://www.wlns.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WRBL-TV Country/Territory Georgia Date 2/04/24 URL https://www.wrbl.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WJET Country/Territory United States Date 2/04/24 URL https://www.yourerie.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet FOX 59 Country/Territory United States Date 2/04/24 URL https://fox59.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet YourCentralValley.com Country/Territory United States Date 2/04/24 URL https://www.yourcentralvalley.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Fox 16 Country/Territory United States Date 2/04/24 URL https://www.fox16.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet OzarksFirst.com Country/Territory United States Date 2/04/24 URL https://www.ozarksfirst.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WWLP.com Country/Territory United States Date 2/04/24 URL https://www.wwlp.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WCBD Country/Territory United States Date 2/04/24 URL https://www.counton2.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WTRF Country/Territory United States Date 2/04/24 URL https://www.wtrf.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WJMN Country/Territory United States Date 2/04/24 URL https://www.upmatters.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet FOX21News.com Country/Territory United States Date 2/04/24 URL https://www.fox21news.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet NBC4 Columbus Country/Territory United States Date 2/04/24 URL https://www.nbc4i.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WREG Country/Territory United States Date 2/04/24 URL https://wreg.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet KHON 2 Country/Territory United States Date 2/04/24 URL https://www.khon2.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WETM 18 Country/Territory United States Date 2/04/24 URL https://www.mytwintiers.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WNCT Country/Territory United States Date 2/04/24 URL https://www.wnct.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Fox40 KTXL Country/Territory United States Date 2/04/24 URL https://fox40.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet YOUR BASIN Country/Territory United States Date 2/04/24 URL https://www.yourbasin.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WANE-TV Country/Territory United States Date 2/04/24 URL https://www.wane.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WVNS Country/Territory United States Date 2/04/24 URL https://www.wvnstv.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet ConchoValleyHomepage.com Country/Territory United States Date 2/04/24 URL https://www.conchovalleyhomepage.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet WTen.com Country/Territory United States Date 2/04/24 URL https://www.news10.com/business/press-releases/cision/20240402NY77717/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%ce%b2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet Kenbridge Victoria Dispatch Country/Territory United States Date 2/04/24 URL https://smb.kenbridgevictoriadispatch.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet Holliston - Local Town Pages Country/Territory United States Date 2/04/24 URL https://pr.hollistontownnews.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet MillisMedway - Local Town Pages Country/Territory United States Date 2/04/24 URL https://pr.millismedwaynews.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet BluegrassLive.com Country/Territory United States Date 2/04/24 URL https://smb.bluegrasslive.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet Leesville Leader Country/Territory United States Date 2/04/24 URL https://smb.theleesvilleleader.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet TheTidewaterNews.com Country/Territory United States Date 2/04/24 URL https://smb.thetidewaternews.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet Luverne Journal Country/Territory United States Date 2/04/24 URL https://smb.luvernejournal.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet Elizabethton.com Country/Territory United States Date 2/04/24 URL https://smb.elizabethton.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet Winchester Sun Country/Territory United States Date 2/04/24 URL https://smb.winchestersun.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet Port Arthur News Country/Territory United States Date 2/04/24 URL https://smb.panews.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet L' Observateur Country/Territory United States Date 2/04/24 URL https://smb.lobservateur.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet Jessamine Journal Country/Territory United States Date 2/04/24 URL https://smb.jessaminejournal.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the... Media name/outlet Smithfield Times Country/Territory United States Date 2/04/24 URL https://smb.smithfieldtimes.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the Media name/outlet Suffolk News Herald Country/Territory United States Date 2/04/24 URL https://smb.suffolknewsherald.com/article/EpicentRx-to-Present-Positive-Phase-2a-Clinical-Data-with-its-AdAPT-001-TGF-b-Trap-Program-in-Checkpoint-Inhibitor-Resistant-Patients-at-the-2024-AACR-Meeting?storyId=660c20a70f3f3147fb98ad0d Persons Christopher Larson